TY - JOUR
T1 - Genetic deletion of IL-19 (interleukin-19) exacerbates atherogenesis in Il19-/-×Ldlr-/- double knockout mice by dysregulation of mRNA stability protein HuR (human antigen R)
AU - Ray, Mitali
AU - Gabunia, Khatuna
AU - Vrakas, Christine N.
AU - Herman, Allison B.
AU - Kako, Farah
AU - Kelemen, Sheri E.
AU - Grisanti, Laurel A.
AU - Autieri, Michael V.
N1 - Publisher Copyright:
© Lippincott Williams and Wilkins. All rights reserved.
PY - 2018/6
Y1 - 2018/6
N2 - Objective-To test the hypothesis that loss of IL-19 (interleukin-19) exacerbates atherosclerosis. Approach and Results-Il19-/- mice were crossed into Ldlr-/- (low-density lipoprotein receptor knock out) mice. Double knockout (dKO) mice had increased plaque burden in aortic arch and root compared with Ldlr-/- controls after 14 weeks of high-fat diet (HFD). DKO mice injected with 10 ng/g per day rmIL-19 had significantly less plaque compared with controls. QRT-PCR and Western blot analysis revealed dKO mice had increased systemic and intraplaque polarization of T cells and macrophages to proinflammatory Th1 and M1 phenotypes, and also significantly increased TNF (tumor necrosis factor)-α expression in spleen and aortic arch compared with Ldlr-/- controls. Bone marrow transplantation suggests that immune cells participate in IL-19 protection. Bone marrow-derived macrophages and vascular smooth muscle cells isolated from dKO mice had a significantly greater expression of inflammatory cytokine mRNA and protein compared with controls. Spleen and aortic arch from dKO mice had significantly increased expression of the mRNA stability protein HuR (human antigen R). Bone marrow-derived macrophage and vascular smooth muscle cell isolated from dKO mice also had greater HuR abundance. HuR stabilizes proinflammatory transcripts by binding AU-rich elements in the 3′ untranslated region. Cytokine and HuR mRNA stability were increased in dKO bone marrow-derived macrophage and vascular smooth muscle cell, which was rescued by addition of IL-19 to these cells. IL-19-induced expression of miR133a, which targets and reduced HuR abundance; miR133a levels were lower in dKO mice compared with controls. Conclusions-These data indicate that IL-19 is an atheroprotective cytokine which decreases the abundance of HuR, leading to reduced inflammatory mRNA stability.
AB - Objective-To test the hypothesis that loss of IL-19 (interleukin-19) exacerbates atherosclerosis. Approach and Results-Il19-/- mice were crossed into Ldlr-/- (low-density lipoprotein receptor knock out) mice. Double knockout (dKO) mice had increased plaque burden in aortic arch and root compared with Ldlr-/- controls after 14 weeks of high-fat diet (HFD). DKO mice injected with 10 ng/g per day rmIL-19 had significantly less plaque compared with controls. QRT-PCR and Western blot analysis revealed dKO mice had increased systemic and intraplaque polarization of T cells and macrophages to proinflammatory Th1 and M1 phenotypes, and also significantly increased TNF (tumor necrosis factor)-α expression in spleen and aortic arch compared with Ldlr-/- controls. Bone marrow transplantation suggests that immune cells participate in IL-19 protection. Bone marrow-derived macrophages and vascular smooth muscle cells isolated from dKO mice had a significantly greater expression of inflammatory cytokine mRNA and protein compared with controls. Spleen and aortic arch from dKO mice had significantly increased expression of the mRNA stability protein HuR (human antigen R). Bone marrow-derived macrophage and vascular smooth muscle cell isolated from dKO mice also had greater HuR abundance. HuR stabilizes proinflammatory transcripts by binding AU-rich elements in the 3′ untranslated region. Cytokine and HuR mRNA stability were increased in dKO bone marrow-derived macrophage and vascular smooth muscle cell, which was rescued by addition of IL-19 to these cells. IL-19-induced expression of miR133a, which targets and reduced HuR abundance; miR133a levels were lower in dKO mice compared with controls. Conclusions-These data indicate that IL-19 is an atheroprotective cytokine which decreases the abundance of HuR, leading to reduced inflammatory mRNA stability.
KW - Animals
KW - Aorta, Thoracic/drug effects
KW - Aortic Diseases/genetics
KW - Atherosclerosis/genetics
KW - Cells, Cultured
KW - Disease Models, Animal
KW - Disease Progression
KW - ELAV-Like Protein 1/genetics
KW - Female
KW - Gene Deletion
KW - Genetic Predisposition to Disease
KW - Interleukin-10/administration & dosage
KW - Interleukins
KW - Macrophages/metabolism
KW - Male
KW - Mice, Inbred C57BL
KW - Mice, Knockout
KW - MicroRNAs/genetics
KW - Muscle, Smooth, Vascular/metabolism
KW - Myocytes, Smooth Muscle/metabolism
KW - Phenotype
KW - Plaque, Atherosclerotic
KW - RNA Stability/drug effects
KW - RNA, Messenger/genetics
KW - Receptors, LDL/deficiency
KW - Tumor Necrosis Factor-alpha/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85051703973&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000439571100014&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1161/ATVBAHA.118.310929
DO - 10.1161/ATVBAHA.118.310929
M3 - Article
C2 - 29674474
SN - 1079-5642
VL - 38
SP - 1297
EP - 1308
JO - Arteriosclerosis, Thrombosis, and Vascular Biology
JF - Arteriosclerosis, Thrombosis, and Vascular Biology
IS - 6
ER -